Management of endometrial cancer in young women

Clinical Obstetrics and Gynecology

Volumn 54, Issue 2, 2011, Pages 219-225

  Shah, Monjri M ^a   Wright, Jason D ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Endometrial cancer; fertility conserving surgery; ovarian preservation; progesterone; young women

Indexed keywords

ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE;

ARTICLE; BODY MASS; CANCER HORMONE THERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; GENETIC PREDISPOSITION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HYPERTENSION; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUAL IRREGULARITY; NULLIPARA; OVULATION INDUCTION; SALPINGOOOPHORECTOMY;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; INFERTILITY, FEMALE; MEDROXYPROGESTERONE ACETATE; OVARIECTOMY; PROGESTINS; RISK FACTORS;

EID: 79955562301     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e318218607c     Document Type: Article

References (20)

1. Lee NK, Cheung MK, Shin JY, et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007;109:655-662. (Pubitemid 46339405)
2. Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105:575-580. (Pubitemid 40271225)
3. Thomas CC, Wingo PA, DolanMS, et al. Endometrial cancer risk among younger, overweight women. Obstet Gynecol. 2009; 114:22-27.
4. Gitsch G, Hanzal E, Jensen D, et al. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol. 1995;85:504-508.
5. Matthews KS, Estes JM, Conner MG, et al. Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol. 2008;111:1161-1166. (Pubitemid 351620352)
6. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;296:1507-1517. (Pubitemid 44465515)
7. Lu KH, Dinh M, Kohlmann W, et al. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105:569-574. (Pubitemid 40271224)
8. Berends MJ, Wu Y, Sijmons RH, et al. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol. 2003;21:4364-4370. (Pubitemid 46621813)
9. Gotlieb WH, Beiner ME, Shalmon B, et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol. 2003;102:718-725. (Pubitemid 37206407)
10. Ramirez PT, Frumovitz M, Bodurka DC, et al. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95:133-138. (Pubitemid 39286288)
11. Ushijima K, Yahata H, Yoshikawa H, et al.Multicenter phase II study of fertilitysparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25:2798-2803. (Pubitemid 47123189)
12. Montz FJ, Bristow RE, Bovicelli A, et al. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002;186:651-657. (Pubitemid 34494341)
13. Yamazawa K, Hirai M, Nishi H, et al. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod. 2007;22:1953-1958. (Pubitemid 47062765)
14. Cade TJ, Quinn MA, Rome RM, et al. Proestogen treatment options for early endometrial cancer. BJOG. 2010;117: 879-884.
15. Eftekhar Z, Izadi-Mood N, Yarandi F, et al. Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experience with 21 patients. Int J Gynecol Cancer. 2009;19:249-252.
16. Lowe MP, Cooper BC, Sood AK, et al. Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia. Gynecol Oncol. 2003; 91:569-572. (Pubitemid 38388152)
17. Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94:456-462. (Pubitemid 39024553)
18. Walsh C, Holschneider C, Hoang Y, et al. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693-699. (Pubitemid 41362170)
19. Wright JD, Buck AM, Shah M, et al. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009;27:1214-1219.
20. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy. Obstet Gynecol. 2008;111:231-241.